Ryufin

Terveystalo Oyj

Finland · FI4000252127 · reports in EUR · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?Fair
Revenue −4.6% in the year to Dec 31, 2025, on the year before.
Is it a good business?Good
It earned 16% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?Fair
Equity is 41% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in EUR.

€1.3B

revenue

11%

operating margin

€93M

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue€1.3B€1.3B€1.3B€1.3B
Operating profit€34M−€15M€116M€138M
Net profit to shareholders€24M−€42M€72M€93M
Earnings per share€0.19−€0.33€0.57€0.73
Dividend per sharen/a€0.28n/a€0.48
Cash from operations€141M€158M€224M€207M
Capital spending€30M€25M€27M€31M
Cash€40M€38M€65M€75M
Total assets€1.5B€1.4B€1.4B€1.4B
Equity€592M€515M€548M€584M

What they do

In the company's own words, from the annual report.

Yhtiö tarjoaa kokonaisvaltaisia hyvinvoinnin, perusterveydenhuollon ja erikoissairaanhoidon palveluja yritys- ja yksityisasiakkaille, sekä julkiselle sektorille

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.